Filepharma Invest SRL
Filepharma Invest reported total assets of €1.10m at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026).
The score of Filepharma Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +93 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Filepharma Invest's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 105,376 € | ||||
| Equity | 439,736 € | ||||
| Cash | 21,268 € | ||||
| EBITDA | 126,950 € | ||||
| Total assets | €1.10m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 18 Aug 2022
Filepharma Invest's financial analysis
- Solvency40.1%sector median: 49.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Filepharma Invest
Filepharma Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0714.928.107
- VAT number
- BE0714928107
- Peppol
- Registered · 0208:0714928107 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Nov 2018
- Registered office
- 7061 Soignies
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Activities of head offices (NACE 70100)
Filepharma Invest (SRL) has been based in Soignies since 2018, active in: activities of head offices. For 2025, it reports a net profit of 105,376 € and equity of 439,736 €; its revenue is not published. Its solvency stands at 40.1%, below the median of its sector (49.8%).
Companies similar to Filepharma Invest
Companies in the same business, of comparable size and area, outside its group.
- Cedm Activities of head offices Sint-Lievens-Houtem · balance sheet €1.08m
- Klementina Activities of head offices Sint-Lievens-Houtem · balance sheet €1.19m
- Fribemo Activities of head offices Wingene · balance sheet €1.24m
- Georgetown Activities of head offices Antwerp · balance sheet 966,096 €
- Jaak Ryckeboer Activities of head offices Zemst · balance sheet €1.18m
- Sugera Holding Activities of head offices Wuustwezel · balance sheet €1.32m
- VEX Activities of head offices Putte · balance sheet 904,260 €
- Just Splendid Activities of head offices Bruges · balance sheet €1.32m
Frequently asked questions about Filepharma Invest
What is the revenue of Filepharma Invest?
Filepharma Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Filepharma Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0714928107 for Filepharma Invest, if the company is VAT-registered. Its company number (CBE) is 0714.928.107.
Where is the registered office of Filepharma Invest?
According to the CBE register, the registered office of Filepharma Invest is in 7061 Soignies.
What is the equity of Filepharma Invest?
At the close of the 2025 financial year, the equity of Filepharma Invest amounts to 439,736 €, a solvency of 40.1% of total assets.
Who manages Filepharma Invest?
The register lists 1 active mandates at Filepharma Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Filepharma Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →